Portable Ultrasound for Interventional Procedures
研究概览
详细说明
Portable ultrasound-guided procedures, including paracentesis, thoracentesis, drain placement, or simple biopsies can be required for patients who are difficult to move, in particular COVID-19 patients, patients in the ICU, or on the floor. Portable ultrasounds have demonstrated a convenient ability to provide a point of care ultrasound diagnostic testing with expanding use in standard clinical care. A number of portable ultrasound systems are in routine clinical use at MGH and have been used for diagnostic procedures (e.g. Butterfly, Hologic, others). Most of the systems are still tethered (transducer is connected via cables to a computer or power) which may represent challenges for contamination, especially in interventional procedures. The Healcerion system is the first FDA approved wireless and battery-operated portable ultrasound system of its kind and is in routine use for diagnostic ultrasounds throughout the world.
The goal of the current study is to compare the utility and practical operations of the advanced Healcerion SONON ultrasound system to a standard wheeled and bulky ultrasound systems in current use (Hitachi, GE). While the Healcerion device has been used at other institutions, it has not been used for interventional procedures at MGH. A comparative efficacy study will allow the investigators to examine the safety and efficacy of the device to complete procedures in a portable setting as well as explore whether images can be improved to reach the more robust imaging capability of wired devices.
研究类型
注册 (预期的)
联系人和位置
学习联系方式
- 姓名:Avik Som, MD
- 电话号码:+1-832-330-7557
- 邮箱:Avik.Som@MGH.HARVARD.EDU
研究联系人备份
- 姓名:Hyungsoon Im, PhD
- 电话号码:+1-617-643-5679
- 邮箱:im.hyungsoon@mgh.harvard.edu
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
描述
Inclusion Criteria:
- The subject has read, signed, and dated the Informed Consent Form (ICF), having been advised of the risks and benefits of the trial in a language understood by the subject.
- Age ≥ 18 years at the date of informed consent form signature and having the ability to comply with the protocol.
- Undergoing a clinically indicated ultrasound-guided procedure, such as paracentesis, thoracentesis, or biopsy.
Exclusion Criteria:
- Patient or health care proxy does not consent
- Patient not undergoing an ultrasound-guided procedure.
学习计划
研究是如何设计的?
设计细节
队列和干预
团体/队列 |
干预/治疗 |
|---|---|
|
Adult patients undergoing an ultrasound-guided procedure
Adult patients undergoing an ultrasound-guided procedure, such as paracentesis, thoracentesis, or biopsy
|
Single-arm, open-label device efficacy study to enroll 200 patients who have been ordered to have an ultrasound-guided procedure by the MGH Interventional Radiology department, including paracentesis, thoracentesis, biopsy, or ultrasound-guided drain placement.
Patients will be restricted to adults who can consent.
The FDA approved Healcerion SONON portable ultrasound (linear and curved) will be used during clinically indicated standard ultrasound-guided procedures following clinical standard of care.
A standard clinical ultrasound will subsequently be used for image guidance as the gold standard.
Images will be compared and improved.
The efficacy of the portable ultrasound will be monitored by the clinical user and any complications within 30 days will be determined by chart review.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Efficacy > 80%
大体时间:Approximately 3 years
|
Efficacy as defined by the operator in successfully completing the procedure using the portable ultrasound.
Reported % of cases the portable ultrasound successfully completed the procedure, stratified by procedure type.
|
Approximately 3 years
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (预期的)
初级完成 (预期的)
研究完成 (预期的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- 2020P003984
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.